Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 6:18 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1585–1608 of 17,751 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control Population Clear all

Conditions: Asthma
Interventions: Placebo once daily, QAW039 150 mg once daily, QAW039 450 mg once daily; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years to 84 Years
Enrollment: 604 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 9
States / cities: Newport Beach, California • Westminster, California • Winter Park, Florida + 6 more

Conditions: Pain, Pain, Postoperative
Interventions: cryoSPHERE Ablation, Bupivacaine; Device · Drug
Lead sponsor: The Methodist Hospital Research Institute; Other
Eligibility: 18 Years to 90 Years
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Malocclusion
Interventions: Fixed Appliance Orthodontic Treatment, OrthoPulse™; Device
Lead sponsor: Biolux Research Holdings, Inc.; Industry
Eligibility: 11 Years to 60 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 3
States / cities: Chandler, Arizona • Peoria, Arizona • Phoenix, Arizona

Conditions: Cardiovascular Risk Factor, Stress, Self Efficacy, Depressive Symptoms, Health Behavior
Interventions: B-SWELL: Midlife Black Women's Stress Reduction Wellness Program, WE: Wellness program for Midlife Black Women; Behavioral
Lead sponsor: University of Cincinnati; Other
Eligibility: 40 Years to 64 Years · Female only
Enrollment: 52 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Trauma/Injury Problem
Interventions: Virtual Reality Hypnosis, Audio Hypnosis, Standard treatment; Behavioral · Other
Lead sponsor: National Institute of General Medical Sciences (NIGMS); NIH
Eligibility: 16 Years and older
Enrollment: 211 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Depression - Major Depressive Disorder, Anxiety, PTSD - Post Traumatic Stress Disorder, Insomnia, Alcohol Use Disorder (AUD), Suicide Ideation
Interventions: Deaf CBT-TS; Behavioral
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years and older
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age, Infant, Premature, Anemia, Neonatal
Interventions: Erythropoietin, Sham Comparator; Drug · Other
Lead sponsor: NICHD Neonatal Research Network; Network
Eligibility: 24 Hours to 96 Days
Enrollment: 318 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1997 – 2000
U.S. locations: 9
States / cities: New Haven, Connecticut • Washington D.C., District of Columbia • Atlanta, Georgia + 6 more

Conditions: Hearing Loss
Interventions: Low-level Laser Therapy, Placebo Comparator: Disabled Laser; Radiation · Other
Lead sponsor: University of Iowa; Other
Eligibility: 18 Years to 75 Years
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Social Needs Screening, Caregiver-care Team Relationships, Social Needs Status, Child Health Status, Caregiver Health Status, Utilization, Health Care
Interventions: Social needs screening protocol; Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Gestational Diabetes
Interventions: Intervention, behavioral lifestyle education; Behavioral
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Chronic Rhinosinusitis With Nasal Polyps
Interventions: Itepekimab (SAR440340), Placebo, Mometasone furoate nasal spray (MFNS); Drug
Lead sponsor: Sanofi; Industry
Eligibility: 18 Years and older
Enrollment: 231 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 21
States / cities: Arcadia, California • Los Angeles, California • Newport Beach, California + 16 more

Conditions: Nicotine Dependent Cigarette Smoker
Interventions: Lung Age feedback and exhaled carbon monoxide, No Lung Age Feedback; Behavioral
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 21 Years and older
Enrollment: 225 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 4
States / cities: Harrisburg, Pennsylvania • Hershey, Pennsylvania • Palmyra, Pennsylvania

Conditions: Schizophrenia, Cigarette Smoking
Interventions: Nicotine replacement therapy, Bupropion, cognitive-behavioral smoking cessation counseling, Mobile Contingency Management, Stay Quit Coach, SMS text messaging; Drug · Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Type 1 Diabetes Mellitus
Interventions: CARES Intervention; Behavioral
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 5 Years to 12 Years
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: Type 2 Diabetes Mellitus
Interventions: Insulin Glargine (HOE901 - U300), Insulin Glargine (HOE901 - U100), Background therapy; Drug
Lead sponsor: Sanofi; Industry
Eligibility: 65 Years and older
Enrollment: 1,014 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 64
States / cities: Saraland, Alabama • Fresno, California • Greenbrae, California + 57 more

Conditions: Cognitive Performance, Brain Structure
Interventions: African Dance, African Cultural Immersion; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 60 Years to 80 Years
Enrollment: 151 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Corneal Transplant Failure
Interventions: Corneal Donor Tissue with Cross Linking, Corneal Donor Tissue without Cross Linking; Procedure
Lead sponsor: Massachusetts Eye and Ear Infirmary; Other
Eligibility: 18 Years and older
Enrollment: 96 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2031
U.S. locations: 12
States / cities: Irvine, California • Los Angeles, California • San Francisco, California + 9 more

Conditions: Alzheimer's Disease
Interventions: VHB937, Placebo; Biological · Other
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 50 Years to 85 Years
Enrollment: 97 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 22
States / cities: Phoenix, Arizona • Irvine, California • La Jolla, California + 19 more

Conditions: HIV
Interventions: HIV knowledge Intervention; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years to 100 Years · Male only
Enrollment: 558 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2015
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Atopic Dermatitis, Atopic, Dermatitis, AD, Eczema
Interventions: ATI-045, Placebo; Drug
Lead sponsor: Aclaris Therapeutics, Inc.; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 53
States / cities: Phoenix, Arizona • Tucson, Arizona • Bryant, Arkansas + 47 more

Conditions: Cerebral Edema, Saline Solution, Hypertonic
Interventions: 3% Sodium Chloride, 23.4% Sodium Chloride, 8.4% Sodium Bicarbonate; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Stanford, California

Conditions: Hispanic Americans, Chronic Disease Prevention, Cancer Prevention, Fruit and Vegetable Consumption
Interventions: The Value of Our Health; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 2
States / cities: Granger, Washington • Seattle, Washington

Conditions: Alzheimer Disease
Interventions: bapineuzumab, placebo; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 50 Years to 88 Years
Enrollment: 1,100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 111
States / cities: Birmingham, Alabama • Goodyear, Arizona • Phoenix, Arizona + 54 more

Conditions: Rhinitis, Allergic, Perennial
Interventions: fluticasone furoate nasal spray, vehicle placebo nasal spray; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 12 Years and older
Enrollment: 550 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 56
States / cities: Oxford, Alabama • Little Rock, Arkansas • Fresno, California + 49 more

Search by objective public record fields.

Systemic Corticosteroids Avoidance Study in Severe Asthma Patients

Cryoablation of Intercostal Nerves for Post-Operative Pain Management in Opioid-Tolerant Patients

The Effect of OrthoPulse Photobiomodulation on the Rate of Tooth Movement During Alignment With Fixed Appliances

Stress-reduction Wellness Program for Midlife Black Women (B-SWELL)

Virtual Reality Pain Control Orthopedic Trauma

Deaf CBT-TS to Reduce Suicide Risk

The Effects of Erythropoietin (EPO) on the Transfusion Requirements of Very Low Birth Weight Infants

The Effect of Low-Level Laser Stimulation on Hearing Thresholds

Addressing Unmet Social Needs Among Hospitalized Children

The OHSU Pregnancy Exercise & Nutrition (PEN) Program

A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps

The Get Quit - Stay Quit Study

Mobile Health Technology to Enhance Abstinence in Smokers With Schizophrenia

Cognitive Adaptations to Reduce Emotional Stress Associated With Type 1 Diabetes

Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Older Patients With Type2 Diabetes Insufficiently Controlled on Their Current Antidiabetic Medications

Rhythm Experience and Africana Culture Trial

ExCrossV Multi Site Trial for Vascularized High Risk Keratoplasty

A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease

HOPE (Harnessing Online Peer Education): Using Online Social Networks for HIV Prevention and Testing

ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis

Small-Volume, Patient-Specific, Balanced Hypertonic Fluid Protocol Validation

Nuestro Valor: Increasing Healthier Food Access for Rural Latino Communities Through a Food Retail Intervention

Study Evaluating the Safety and Efficacy of Bapineuzumab in Alzheimer Disease Patients

A Clinical Study With Fluticasone Furoate Nasal Spray And Vehicle Placebo For The Treatment Of Perennial (Year-round) Allergic Rhinitis